A detailed history of Natixis Investment Managers International transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Natixis Investment Managers International holds 20,476 shares of EW stock, worth $1.41 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
20,476
Previous 9,216 122.18%
Holding current value
$1.41 Million
Previous $851,000 58.75%
% of portfolio
0.1%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $672,222 - $1.06 Million
11,260 Added 122.18%
20,476 $1.35 Million
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $29,505 - $33,008
-350 Reduced 3.66%
9,216 $851,000
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $30,611 - $40,326
-422 Reduced 4.23%
9,566 $914,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $2,962 - $3,732
-48 Reduced 0.48%
9,988 $761,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $19,259 - $25,959
-278 Reduced 2.7%
10,036 $695,000
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $27,353 - $31,694
336 Added 3.37%
10,314 $972,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $47,674 - $54,255
-642 Reduced 6.05%
9,978 $825,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $1.24 Million - $1.61 Million
-15,034 Reduced 58.6%
10,620 $877,000
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $1.54 Million - $2.28 Million
17,767 Added 225.27%
25,654 $2.44 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $804,158 - $1.01 Million
7,887 New
7,887 $928,000
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $428,642 - $525,897
-9,236 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $55,388 - $70,332
1,212 Added 15.1%
9,236 $1.61 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $340,618 - $411,631
8,024 New
8,024 $1.17 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $147,898 - $172,410
-4,377 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $158,841 - $169,958
4,377
4,377 $478,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Natixis Investment Managers International Portfolio

Follow Natixis Investment Managers International and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.